Feline mammary carcinomas (FMC) are highly metastatic tumours frequently (>80%) displaying metastasis to the regional lymph nodes, lungs, pleura, and liver. Historically, the treatment of FMC has been surgery; however, at the time of diagnosis, FMC isoften in an advanced stage due to its rapid progression. Following surgery, the median disease free survival reported is less than a year with a 2-year survival rate of less than 20%. Adjuvant chemotherapy (e.g. doxorubicin) has not shown benefit in delaying relapse or prolonging life with FMC.
展开▼
